Sonova is one of the world's largest manufacturers and distributors of hearing aids... Show more
The RSI Oscillator for SONVF moved out of oversold territory on June 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where SONVF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SONVF as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
SONVF moved below its 50-day moving average on June 20, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SONVF crossed bearishly below the 50-day moving average on June 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for SONVF entered a downward trend on July 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.653) is normal, around the industry mean (24.504). P/E Ratio (23.041) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (2.129) is also within normal values, averaging (5.667). Dividend Yield (0.018) settles around the average of (0.018) among similar stocks. P/S Ratio (3.994) is also within normal values, averaging (43.111).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SONVF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SONVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
Industry MedicalSpecialties
A.I.dvisor tells us that SONVF and STSS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONVF and STSS's prices will move in lockstep.
Ticker / NAME | Correlation To SONVF | 1D Price Change % | ||
---|---|---|---|---|
SONVF | 100% | N/A | ||
STSS - SONVF | 21% Poorly correlated | +1.75% | ||
HSDT - SONVF | 21% Poorly correlated | -3.69% | ||
SAUHY - SONVF | 20% Poorly correlated | -0.89% | ||
SONVY - SONVF | 15% Poorly correlated | -1.34% | ||
SMMNY - SONVF | 12% Poorly correlated | -1.31% | ||
More |